Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8+ tissue-resident memory T cells

Immunity(2021)10.1016/j.immuni.2021.11.017Source: DataRank Database

Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8+ tissue-resident memory T cells is a research paper published in Immunity (2021). On theSindex it has a DataRank of 0. It has been cited 119 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access119 citations

Download PDF

Cite:

Linked data & code

geo gen cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 5.56)OA: greenTopics (34)Linked Datasets (14)DataCite Reuse (14)IDs (PubMed, PMC, OpenAlex)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Matthew A. Huggins ORCID,Kelsey M. Wanhainen ORCID,Todd P. Knutson ORCID,Hanbin Lu,Hristo Georgiev ORCID

Live enrichment

PubMed:34932944 PMC:PMC8755622 OpenAlex:https://openalex.org/W4200316966

NIAID

Grant: R01 AI038903

NIAID

Grant: AI145147

NIAID NIH HHS

Grant: R01 AI145147

University of Minnesota

National Institutes of Health

Minnesota Supercomputing Institute, University of Minnesota

FWCI

5.56

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8755622

BRONZEhttps://doi.org/10.1016/j.immuni.2021.11.017

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8755622

publisherhttps://api.elsevier.com/content/article/PII:S1074761321005094?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761321005094?httpAccept=text/plain

Fields of Study

T-cell and B-cell ImmunologyImmune Cell Function and InteractionImmunotherapy and Immune ResponsesMedicineBiology

MeSH Terms

Memory T CellsAnimalsCell DifferentiationCells, CulturedLymphocyte ActivationMice, Inbred C57BLSignal TransductionMice, KnockoutCD8-Positive T-LymphocytesAntibodies, BlockingAdoptive TransferPhosphatidylinositol 3-KinasesMiceInducible T-Cell Co-Stimulator ProteinInducible T-Cell Co-Stimulator Ligand

Keywords

Priming (agriculture)CD8Cytotoxic T cellBiologyCell biologyCD28EffectorT cellImmunologyImmune systemGeneticsICOSPI3KResident Memory T cells

Additional file 3 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651058.v1figshare

Additional file 3 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651058figshare

Additional file 2 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651055.v1figshare

Additional file 2 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651055figshare

Additional file 1 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651052.v1figshare

Additional file 1 of LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study

10.6084/m9.figshare.26651052figshare

Additional file 1 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605067figshare

Additional file 1 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605067.v1figshare

Additional file 2 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605070.v1figshare

Additional file 2 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605070figshare

Additional file 3 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605073.v1figshare

Additional file 3 of Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy

10.6084/m9.figshare.22605073figshare

Additional file 1 of ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade

10.6084/m9.figshare.23273359.v1figshare

10.6084/m9.figshare.23273359figshare

Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8+ tissue-resident memory T cells

FAIR Checklist

Authors (13)

Funding (6 grants)

Impact

Open Access

Topics

Linked Datasets (14)

Annotations (Europe PMC)